Niki BioSolutions, Inc. Accumulated Other Comprehensive Income
Niki BioSolutions, Inc. (NIKI) had Accumulated Other Comprehensive Income of -$92.31 thousand as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-05-11
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$92.31K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$158.81K.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$169.16K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $89.16K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | -$92.31K S-4/A · filed 2026-05-11 |
| 2025-09-30 | -$158.81K 6-K · filed 2026-01-22 |
| 2025-06-30 | -$169.16K 6-K · filed 2025-10-08 |
| 2024-12-31 | $89.16K S-4/A · filed 2026-05-11 |
| 2024-06-30 | -$9.76K 6-K · filed 2024-12-20 |
| 2023-12-31 | -$10.62K 6-K · filed 2025-10-08 |
| 2023-06-30 | $26.32K 6-K · filed 2023-12-22 |
| 2022-12-31 | $33.81K 20-F · filed 2024-04-30 |
| 2022-06-30 | $29.33K 6-K · filed 2022-09-30 |
| 2021-12-31 | -$2.02K 20-F · filed 2023-04-28 |
| 2021-06-30 | $28.27K 6-K · filed 2021-09-15 |
| 2020-12-31 | $53.30K 20-F/A · filed 2023-01-17 |
| 2020-06-30 | $25.62K 6-K · filed 2020-09-02 |
| 2019-12-31 | -$5.55K 20-F · filed 2021-04-19 |
| 2018-12-31 | -$1.48M 20-F · filed 2020-04-29 |
| 2017-12-31 | -$367.78K 20-F · filed 2019-04-15 |